DSM-Firmenich holds its 200-day line, shares in the Swiss SMI health cluster
Published on 06/25/2026 at 18:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 18:22.
DSM-Firmenich (CH1216478797) starts Thursday trade on SIX Swiss Exchange with a steady technical profile. The stock trades close to its 200-day moving average, while the Swiss SMI and broader SPI indices edge higher on the day according to Swiss market data.
How DSM-Firmenich trades today
On SIX, DSM-Firmenich shares are quoted around 90.00 Swiss francs in afternoon trading, broadly in line with recent sessions and keeping the chart picture muted but stable. The broader SPI index is up around 0.7 percent, underlining a supportive Swiss equity backdrop for large-cap health and nutrition names.
The stock remains part of the Swiss large-cap health and chemicals cluster alongside peers such as Lonza and Givaudan, which often serve as sector comparables for investors considering exposure to specialty nutrition and ingredients.
Analyst and sector context
DSM-Firmenich was created by the merger of Dutch group DSM and Swiss player Firmenich, and is now tracked by major houses like UBS, JPMorgan and Goldman Sachs within their European chemicals and health-nutrition coverage according to recent consensus overviews. Analysts typically benchmark the shares against other specialty ingredients names and against the SMI and SPI index performance.
Sector commentary from Swiss financial media highlights a constructive tone for selected SPI Extra constituents in health-related industries, with several mid-cap names posting notable gains on Thursday. This underpins the view that investor appetite for Swiss-listed health and life-science exposure remains intact.
Background and price data on DSM-Firmenich
More news, prices and analysis on the DSM-Firmenich shares can be found in the dedicated topic section and on the company’s Investor Relations page.
What the company sells
DSM-Firmenich is positioned as a global science-based company working across nutrition, health and beauty, with offerings ranging from vitamins and nutritional ingredients to fragrance and flavor solutions for food, beverage and personal care customers according to its corporate overview. Revenue streams come from supplying these specialty ingredients to branded consumer-product makers worldwide.
Where the stock trades today
The DSM-Firmenich shares (CH1216478797) trade on 2026-06-25, 17:40 on SIX Swiss Exchange at approximately 90.00 Swiss francs, in a Swiss large-cap segment that saw the SMI index gain around 0.8 percent on the day.
DSM-Firmenich at a glance
- Company: DSM-Firmenich AG
- ISIN: CH1216478797
- WKN: not available
- Ticker: DSMF
- Trading venue: SIX Swiss Exchange
- Price (as of 2026-06-25, 17:40): 90.00 CHF
- Market cap: approximately 30 billion CHF (as of 2026-06-25)
- Sector / industry: Specialty chemicals, nutrition and health ingredients
- Index membership: SMI / SPI
- Next earnings date: not officially scheduled
This text is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All data and assessments are based on sources believed to be reliable but cannot be guaranteed. Investors should conduct their own research or consult a professional advisor before making investment decisions.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
